Schering Clarinex Approval Comes In Time For Big Spring Push

Schering-Plough has received approval for the Claritin successor Clarinex in time to permit a big market build-up for the spring allergy season

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet